Provinces agree to fund Hemlibra for inhibitor patients
Montreal, June 13, 2019 – Canadian Blood Services has announced the availability of Hemlibra (emicizumab injection) for individuals with hemophilia A and inhibitors.
Click on the link below to read the message sent to CHS President, Paul Wilton.
Hemlibra available to Quebec patients with hemophilia A and inhibitors
May 9, 2019 – Montreal – Héma-Québec informed the Canadian Hemophilia
Society-Quebec Chapter (CHSQ) today that Hemlibra® will be available for the
treatment of patients with hemophilia A and inhibitors in Quebec in the coming